Literature DB >> 3762642

Hepatitis B virus RNA transcripts and DNA in chronic liver disease.

O Yokosuka, M Omata, F Imazeki, Y Ito, K Okuda.   

Abstract

To study the relation between gene expression of hepatitis B virus (HBV) and liver disease, we studied HBV RNA transcripts and DNA in liver-biopsy specimens from 30 patients with chronic liver disease (17 seropositive for hepatitis B surface antigen and 13 seronegative). HBV-specific RNA was found in all the seropositive patients and in none of the seronegative patients. Two major RNAs, sizes 29S (long) and 21S (short), were found in nine seropositive patients, of whom seven had free HBV DNA and eight were seropositive for hepatitis B e antigen. Six of the nine patients had hepatitis B core antigen in hepatocytes and active liver disease. In contrast, inactive liver disease was noted in the remaining eight seropositive patients, who had only one (21S) RNA. None of these patients had free HBV DNA (five of eight had integrated DNA) or hepatitis B core antigen in hepatocytes. Hybridization analysis suggested that 29S and 21S RNAs are messenger RNAs of hepatitis B core antigen and hepatitis B surface antigen, respectively. These data indicate that the free DNA and its products are causally related to the activity of liver disease and that once HBV DNA has been integrated, the disease will become quiescent. None of the determinants were identified in patients seronegative for hepatitis B surface antigen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762642     DOI: 10.1056/NEJM198611063151903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Occurrence of hepatocellular carcinoma in chronic viral hepatitis.

Authors:  M Omata; S Takano
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Duck hepatitis B virus replication in primary bile duct epithelial cells.

Authors:  J Y Lee; J G Culvenor; P Angus; R Smallwood; A Nicoll; S Locarnini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency.

Authors:  Claudia E Oropeza; Alan McLachlan
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

Review 4.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

5.  Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.

Authors:  N Kato; O Yokosuka; M Omata; K Hosoda; M Ohto
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients.

Authors:  Y M Lo; E S Lo; W Z Mehal; M Sampietro; G Fiorelli; G Ronchi; C H Tse; K A Fleming
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

7.  Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.

Authors:  A K Raney; H B Le; A McLachlan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1.

Authors:  A K Raney; A J Easton; D R Milich; A McLachlan
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Hepatitis B virus replication within the human spleen.

Authors:  A M Di Bisceglie; J H Hoofnagle
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

10.  Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter.

Authors:  P Zhang; A K Raney; A McLachlan
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.